Publications

Year of Publication Title Faculty Association
2008 Progesterone receptors: form and function in brain. Roberta Diaz Brinton, Ph.D
2008 Novel D-amino acid tetrapeptides produce potent antinociception by selectively acting at peripheral kappa-opioid receptors. Tally Largent-Milnes, PhD, Frank Porreca, PhD, Todd Vanderah, PhD
2008 Regenerative potential of allopregnanolone. Roberta Diaz Brinton, Ph.D
2008 Progesterone and estrogen regulate oxidative metabolism in brain mitochondria. Roberta Diaz Brinton, Ph.D
2008 The role of COX-2 in heart pathology. John M. Streicher, PhD
2008 Estradiol-17beta-induced human neural progenitor cell proliferation is mediated by an estrogen receptor beta-phosphorylated extracellularly regulated kinase pathway. Roberta Diaz Brinton, Ph.D
2008 Intrathecal Raf-1-selective siRNA attenuates sustained morphine-mediated thermal hyperalgesia. Tally Largent-Milnes, PhD, Todd Vanderah, PhD
2008 Estrogen and hippocampal plasticity in rodent models. Roberta Diaz Brinton, Ph.D
2008 Oxycodone plus ultra-low-dose naltrexone attenuates neuropathic pain and associated mu-opioid receptor-Gs coupling. Tally Largent-Milnes, PhD, Todd Vanderah, PhD
2007 Identification of Fn14/TWEAK receptor as a potential therapeutic target in esophageal adenocarcinoma.
2007 Profiling of selenomethionine responsive genes in colon cancer by microarray analysis.
2006 Epigenetic inactivation of the HOXA gene cluster in breast cancer.
2006 Pharmacogenomics of the polyamine analog 3,8,13,18-tetraaza-10,11-[(E)-1,2-cyclopropyl]eicosane tetrahydrochloride, CGC-11093, in the colon adenocarcinoma cell line HCT1161.
2006 AP-2alpha and AP-2gamma are transcriptional targets of p53 in human breast carcinoma cells.
2005 Atorvastatin for the treatment of mild to moderate Alzheimer disease: preliminary results. Jeffrey J. Lochhead, PhD
2005 Atorvastatin therapy lowers circulating cholesterol but not free radical activity in advance of identifiable clinical benefit in the treatment of mild-to-moderate AD. Jeffrey J. Lochhead, PhD
2005 Serotonin-related gene expression in female monkeys with individual sensitivity to stress. John M. Streicher, PhD
2004 Proteasome-dependent degradation of cytochromes P450 2E1 and 2B1 expressed in tetracycline-regulated HeLa cells. John M. Streicher, PhD
2004 Performance evaluation of commercial short-oligonucleotide microarrays and the impact of noise in making cross-platform correlations.
2004 The acetyltransferase p300/CBP-associated factor is a p53 target gene in breast tumor cells.
2004 The chemopreventive agent alpha-difluoromethylornithine blocks Ki-ras-dependent tumor formation and specific gene expression in Caco-2 cells.
2003 Low-level arsenite induced gene expression in HEK293 cells.
2003 Mutant p53 and aberrant cytosine methylation cooperate to silence gene expression.
2002 Diverse actions of ovarian steroids in the serotonin neural system. John M. Streicher, PhD
2002 Development and molecular characterization of HCT-116 cell lines resistant to the tumor promoter and multiple stress-inducer, deoxycholate.

Pages